Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4332163 | 4122500 | I | 4332163-0 | 20040123 | 20040312 | 20040331 | EXP | EWC040338435 | ELI LILLY AND COMPANY | 65 | YR | F | N | 20040324 | MD | 20040123 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4332163 | 1004762055 | PS | OLANZAPINE | 1 | ORAL | 2.5 MG/1 DAY | D | 20592 | |||
| 4332163 | 1004773689 | C | FLUX (SODIUM FLUORIDE) | 2 | |||||||
| 4332163 | 1004773690 | C | SIFROL (PRAMIPEXOLE DIHYDROCHLORIDE) | 2 | |||||||
| 4332163 | 1004773698 | C | LISINOPRIL | 1 | |||||||
| 4332163 | 1004773699 | C | EPIXIAN | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4332163 | 1004762055 | ANXIETY |
| 4332163 | 1004762055 | RESTLESSNESS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4332163 | DE |
| 4332163 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4332163 | CIRCULATORY COLLAPSE |
| 4332163 | LOSS OF CONSCIOUSNESS |
| 4332163 | NERVOUS SYSTEM DISORDER |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4332163 | CR |
| 4332163 | FGN |
| 4332163 | HP |
| 4332163 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4332163 | 1004762055 | 20030501 |